This review article aims to synthesize the evidence regarding nonalcoholic fatty liver disease (NAFLD) as a systemic disorder. We critically discuss the metabolic syndrome and its components; the cardiovascular and the endocrine system; chronic respiratory disorders; the musculoskeletal system; the skin; and extrahepatic tumors. We conclude that, while some of these extra-hepatic conditions clearly predispose to the development of secondary forms of NAFLD (typically hypothyroidism-induced NAFLD), others result from pre-existent NAFLD (e.g., certain extra-hepatic tumors) and others (such as Type 2 Diabetes) have, with NAFLD, mutual and bidirectional associations. Analyzed data imply that NAFLD is not merely a hepatic disease. It is also and ...
AimsTo conduct a systematic literature review to identify recent epidemiological, biomarker, genetic...
Nonalcoholic fatty liver disease (NAFLD) is increasingly being diagnosed worldwide and is strongly a...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities associated with o...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD in...
Abstract Purpose of review Clinical, epidemiological and biochemical data strongly support the conc...
In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD) challengi...
Nonalcoholic fatty liver disease (NAFLD) is described as exposition of multiplex liver metabolic dis...
Abstract Nonalcoholic fatty liver disease is increasingly regarded as a hepatic manifestation of met...
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sha...
As the number of individuals with non-alcoholic fatty liver disease (NAFLD) has increased, the influ...
The development of nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metaboli...
Non-alcoholic fatty liver disease (NAFLD) isusually a silent disease that occurs in a very high prop...
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestatio...
AimsTo conduct a systematic literature review to identify recent epidemiological, biomarker, genetic...
Nonalcoholic fatty liver disease (NAFLD) is increasingly being diagnosed worldwide and is strongly a...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities associated with o...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD in...
Abstract Purpose of review Clinical, epidemiological and biochemical data strongly support the conc...
In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD) challengi...
Nonalcoholic fatty liver disease (NAFLD) is described as exposition of multiplex liver metabolic dis...
Abstract Nonalcoholic fatty liver disease is increasingly regarded as a hepatic manifestation of met...
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sha...
As the number of individuals with non-alcoholic fatty liver disease (NAFLD) has increased, the influ...
The development of nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metaboli...
Non-alcoholic fatty liver disease (NAFLD) isusually a silent disease that occurs in a very high prop...
The conventional paradigm of nonalcoholic fatty liver disease representing the "hepatic manifestatio...
AimsTo conduct a systematic literature review to identify recent epidemiological, biomarker, genetic...
Nonalcoholic fatty liver disease (NAFLD) is increasingly being diagnosed worldwide and is strongly a...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities associated with o...